Mecarsos, Leizel, II. A.
HRN: 26-61-99 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/30/2025
CEFTRIAXONE 1G (VIAL)
01/30/2025
02/05/2025
IV
2g
OD
Cholecystolithiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes